Silverarc Capital Management »

Aeglea Biotherapeutics shares owned by Silverarc Capital Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Silverarc Capital Management from 13F filings

Historical chart of Silverarc Capital Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Silverarc Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Silverarc Capital Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.2M 188k 32.76